Evolus
EOLS • NASDAQ • Stock Fundamentals
Evolus is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO David Moatazedi, with a market cap of $428.7M.
Market Cap$428.7M
Employees279.0
CEODavid Moatazedi
CountryUnited States of America
Healthcare
Drug Manufacturers - Specialty & Generic
Most Recent EarningsMay 4, 2026 · 1 month 10 days agoQ1 2026
View reportNext EarningsAug 4, 2026 · in 2 monthsAfter Market Close · Q2 2026
Financials
Based on Q1 2026 filing
Evolus FAQ
Common questions about Evolus
Evolus (EOLS) has a market capitalization of $428.7M and trades on NASDAQ.
Evolus has approximately 279 employees.